Chemed Corp (FRA:CXM) Stock Price, Trades & News

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Financial Strength

7/10

Name	Current	Vs Industry
Cash-To-Debt	0.14
Equity-to-Asset	0.53
Debt-to-Equity	0.36
Debt-to-EBITDA	0.67
Interest Coverage	107.38
Piotroski F-Score	5/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	10.52	Distress Grey Safe
Beneish M-Score	-3.02	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

7/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	7.4
	3-Year EBITDA Growth Rate	3.9
	3-Year EPS without NRI Growth Rate	4.7
	3-Year FCF Growth Rate	10.4
	3-Year Book Growth Rate	10
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	10.52
	Future 3-5Y Total Revenue Growth Rate Estimate	6.4

Momentum Rank

6/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	26.33
	9-Day RSI	35.13
	14-Day RSI	41.46
	3-1 Month Momentum %	26.88
	6-1 Month Momentum %	38.82
	12-1 Month Momentum %	23.56

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	0.91
	Quick Ratio	0.89
	Cash Ratio	0.13
	Days Inventory	1.67
	Days Sales Outstanding	27.77
	Days Payable	13.2

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	0.49
	Dividend Payout Ratio	0.11
	3-Year Dividend Growth Rate	14.1
	Forward Dividend Yield %	0.55
	5-Year Yield-on-Cost %	0.79
	3-Year Average Share Buyback Ratio	2.7
	Shareholder Yield %	9.13

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	33.11
	Operating Margin %	13.57
	Net Margin %	10.6
	EBITDA Margin %	16.91
	FCF Margin %	12.46
	OCF Margin %	15.01
	ROE %	27.87
	ROA %	17.2
	ROIC %	18.6
	3-Year ROIIC %	-24.84
	ROC (Joel Greenblatt) %	107.49
	ROCE %	28.6
	Years of Profitability over Past 10-Year	10
	Moat Score	5
	Tariff Resilience Score	8

GF Value Rank

8/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	25.92
	Forward PE Ratio	18.52
	PE Ratio without NRI	23.21
	Shiller PE Ratio	28.55
	Price-to-Owner-Earnings	22.98
	PEG Ratio	9.67
	PS Ratio	2.74
	PB Ratio	8.12
	Price-to-Tangible-Book	128.45
	Price-to-Free-Cash-Flow	22.05
	Price-to-Operating-Cash-Flow	18.29
	EV-to-EBIT	18.79
	EV-to-Forward-EBIT	14.57
	EV-to-EBITDA	15.95
	EV-to-Forward-EBITDA	13.63
	EV-to-Revenue	2.7
	EV-to-Forward-Revenue	2.43
	EV-to-FCF	21.63
	Price-to-GF-Value	0.75
	Price-to-Projected-FCF	1.67
	Price-to-DCF (Earnings Based)	1.12
	Price-to-DCF (FCF Based)	0.99
	Price-to-Median-PS-Value	0.78
	Price-to-Graham-Number	11.51
	Earnings Yield (Greenblatt) %	5.32
	FCF Yield %	4.8
	Forward Rate of Return (Yacktman) %	7.32

Financials (Next Earnings Date:2026-10-28 Est.)

Annual Quarterly TTM

FRA:CXM's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Chemed Corp Operating Data

Annual Quarterly

FRA:CXM's Complete Operating Data

No operating data available for Chemed Corp.

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Chemed Corp Executives

Details

GF Value™: €582.12

FRA:CXM

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with CXM. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	2,231.54
	EPS (TTM) (€)	17.12
	Beta	0.0362
	3-Year Sharpe Ratio	-0.03
	3-Year Sortino Ratio	-0.04
	Volatility %	22.9
	14-Day RSI	41.46
	14-Day ATR (€)	4.045009
	20-Day SMA (€)	449
	12-1 Month Momentum %	23.56
	52-Week Range (€)	316 - 474
	Shares Outstanding (Mil)	13.07

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	5
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Chemed Corp Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Chemed Corp Stock Events

Financials Calendars

Event	Date	Price (€)
Fourth quarter earnings conference call for 2026	2027-02-26 10:00	In 166 days
Annual report for 2026	2027-02-26	In 165 days
Fourth quarter earnings results for 2026	2027-02-25	In 164 days
Third quarter earnings conference call for 2026	2026-10-29 10:00	In 46 days
Third quarter earnings results for 2026	2026-10-28	In 44 days
Guidance call for 2026	2026-09-15 10:55	In 2 days
USD 0.700000 Cash Dividend	2026-08-17	462.00 (+0.00%)
Second quarter earnings conference call for 2026	2026-07-29 10:00	444.00 (+0.00%)
Second quarter earnings results for 2026	2026-07-28	444.00 (+0.00%)
USD 0.600000 Cash Dividend	2026-05-28	374.00 (+0.00%)

Show

Entries

Chemed Corp Frequently Asked Questions

What is Chemed Corp(FRA:CXM)'s stock price today?

The current price of FRA:CXM is €438.00. The 52 week high of FRA:CXM is €474.00 and 52 week low is €316.00.

When is next earnings date of Chemed Corp(FRA:CXM)?

The next earnings date of Chemed Corp(FRA:CXM) is 2026-10-28 Est..

Does Chemed Corp(FRA:CXM) pay dividends? If so, how much?

The Dividend Yield % of Chemed Corp(FRA:CXM) is 0.49% (As of Today), Highest Dividend Payout Ratio of Chemed Corp(FRA:CXM) was 0.14. The lowest was 0.07. And the median was 0.08. The Forward Dividend Yield % of Chemed Corp(FRA:CXM) is 0.55%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
	CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties -- CHE	2026-09-03
	CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties -- CHE	2026-08-20
	Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor	2026-03-16
	New VITAS® Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home	2025-11-25
	Chemed To Report Third-Quarter 2025 Earnings October 28, Related Conference Call To Be Held On October 29	2025-10-01
	VITAS® Healthcare, Leading Hospice Provider, Named a 2025 Top Workplace in Healthcare by Top Workplaces USA	2025-09-25
	Chemed Corporation to Present at the Jefferies 2025 Healthcare Services Conference	2025-09-23
	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents	2025-08-01
	Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure	2025-07-29
	Chemed To Report Second-Quarter 2025 Earnings July 29, 2025	2025-06-27

10/Page

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.